Brain Cancer

Nonhemispheric Tumor Location, Female Sex, and Younger Age at Treatment are Independent Risk Factors of High-Grade Glioma

Persistent surveillance of children treated for high-grade glioma “is highly recommended as standard of care” to minimize late effects of treatment and ensure long-term survival, the first systematic investigation of neuropsychological functioning, behavior, and quality of life (QoL) in this population concluded in the Journal of Clinical Oncology published online February 21.

New ASTRO Brain Metastases Guideline: Treatment Selection Should Mirror Most Important Endpoint

Survival, local treated lesion control, distant brain control, or neurocognitive preservation — what is the most important endpoint for a patient newly diagnosed with intraparenchymal brain metastases? The answer to that question should be the deciding factor in selecting the most appropriate radiotherapeutic and/or surgical intervention, according to a new guideline developed by the American Society for Radiation Oncology (ASTRO).

Updated Tool Helps Predict Outcome in Brain Metastases

The updated Graded Prognostic Assessment (GPA), a diagnosis-specific, predictive index for cancer patients with brain metastases, helps clinicians estimate survival, select appropriate treatment, and stratify patients for clinical trials, according to a study published online December 27 in the Journal of Clinical Oncology.

Acupuncture May Help Chemo-Induced Peripheral Neuropathy

The addition of acupuncture to best medical care for chemotherapy-induced peripheral neuropathy (CIPN) may have a positive effect, according to a pilot study published online December 5, 2011 in Acupuncture in Medicine.

Next post in Home